Asia-Pacific prebiotics for infant formula market is projected to register a substantial CAGR in the forecast period 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Country (Japan, China, South Korea, India, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, New Zealand, Vietnam and rest of Asia-Pacific), Market Trends and Forecast to 2027
Some of the major factors contributing to the growth of the Asia-Pacific market:

? Rising Number from Preterm/Premature Babies
? Increasing disposable income due to rising economy


Market Players:
The key market players for Asia-Pacific prebiotics for infant formula market are listed below:
- Jennewein Biotechnologie GmbH
- zuChem Inc
- Biosynth Carbosynth
- Elicityl SA Dextra Laboratories Limited
- Glycom A/S
- Tereos
- Ingredion Incorporated
- Royal FrieslandCampina N.V
- Sudzucker AG
- Cargill, Incorporated
- Fonterra Co-operative Group
- Royal Cosun
- COSUCRA
- New Francisco (Yunfu City) Biotechnology Corporation Limited
- Dana Dairy Group
- Glycosyn LLC
- DuPont